Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Napro Biotherapeutics Incorporated

NaPro BioTherapeutics, Inc. is a natural product pharmaceutical company focused primarily on the development, manufacture and commercializa tion of paclitaxel, a naturally-occurring anti-cancer agent found in certain species of yew (Taxus) trees.


Contact Details:
6304 Spine Road, Unit A
Boulder
CO
80301
United States of America
Tel:303 530 3891
Fax:
Email:
WWW:

www.naprobio.com/




Loading...

Recent Publications by Napro Biotherapeutics Incorporated:

Gene editing of a human gene in yeast artificial chromosomes using modified single-stranded DNA and dual targeting.
A single-nucleotide polymorphism (SNP) in a human gene can alter the...
28th December, 2004
NaPro BioTherapeutics, Genomics Pharmacogenomics J. 2004;4(3):175-83.
DOI Direct Link
Natural products in drug discovery--organizing for success.
A single-nucleotide polymorphism (SNP) in a human gene can alter the...
28th September, 2002
NaPro BioTherapeutics, Inc., Boulder, CO 80301, USA. P R Health Sci J. 2002 Jun;21(2):91-5.

BioNews Results for Napro Biotherapeutics Incorporated:

Talecris to Invest $268.7 Million to Expand its Manufacturing Facility in Clayton
Genetic Engineering News:  Nov 15 2009 8:17AM Matching: biotherapeutics
Drug firm expanding NC operation, adding 260 jobs
WCNC:  Nov 15 2009 2:58AM Matching: biotherapeutics
Rockland job losses could hit 600 by 2011
Lower Hudson Online:  Nov 14 2009 10:50PM Matching: biotherapeutics
Talecris to Invest $268.7 Million to Expand its Manufacturing Facility in Clayton
Pharma Live:  Nov 14 2009 10:40PM Matching: biotherapeutics
Drug firm expanding N.C. operations, adding 260 jobs
Fayetteville Online:  Nov 14 2009 5:13PM Matching: biotherapeutics
Promote your company here: BioNewsCast - Press Release Distribution

View more Napro Biotherapeutics Incorporated news.

Napro Biotherapeutics Incorporated Patents:

US Patent No.Title
6770670 Injectable composition
5977164 Stabilized pharmaceutical composition
5972992 Injectable composition
5948919 Paclitaxel synthesis from precursor compounds and methods of producing the same
5914411 Alternate method for acylating 10-deacetylbaccatin III selectively at the C-10 position

View more Napro Biotherapeutics Incorporated patents.

Napro Biotherapeutics Incorporated (PRW) Financial information Links from Barchart

PRW Quote from from Barchart.com
PRW Chart from from Barchart.com
PRW Profile from from Barchart.com
PRW Opinion from from Barchart.com

View more Napro Biotherapeutics Incorporated finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 849 times since April 2007, the link to the organisation's website has been followed 173 times

Recent Search Terms used to find this page: napro biotherapeutics boulder | napro biotherapeutics boulder | NAPRO | biotherapeutics | napro biotherapeutics inc boulder CO | napro bio therapeutics | napro | biotherapeutics | napro | NaPro BioTherapeutics | .

Search for more companies in Boulder

Search for more companies in CO



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Napro Biotherapeutics Incorporated

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.